A long road for stem cells to cure sick hearts: update on recent clinical trials
- PMID: 22396692
- PMCID: PMC3291729
- DOI: 10.4070/kcj.2012.42.2.71
A long road for stem cells to cure sick hearts: update on recent clinical trials
Abstract
The contribution of stem cells to cure damaged hearts has finally been unraveled. A large number of preclinical and clinical studies have showed beneficial outcomes after myocardial infarction. In this review, the current understanding of stem cell therapy in preclinical and clinical experiences is summarized. Stem cells from bone marrow have shown a potential to improve cardiac performance after myocardial infarction in animal and early clinical studies. Clinical trials from all over the world have provided safety assessments of stem cell therapy with marginal improvement of clinical outcomes. Thus, further investigations should be encouraged to resolve the discrepancies between studies, clinical issues, and unclear translational findings. This review provides information and commentary on key trials for stem cell-based treat-ment of cardiovascular disease.
Keywords: Animal experimentation; Clinical trial; Myocardial infarction; Peer review, research; Stem cells.
Conflict of interest statement
The authors have no financial conflicts of interest.
Similar articles
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Stem cell therapy in neurodegenerative diseases: From principles to practice.Neural Regen Res. 2012 Aug 15;7(23):1822-31. doi: 10.3969/j.issn.1673-5374.2012.23.009. Neural Regen Res. 2012. PMID: 25624807 Free PMC article. Review.
-
Bringing cardiac cell therapy with bone marrow stem cells to the clinic: where are we now?Future Cardiol. 2007 Sep;3(5):515-8. doi: 10.2217/14796678.3.5.515. Future Cardiol. 2007. PMID: 19804306
-
Stem Cell Therapy for the Treatment of Myocardial Infarction: How Far Are We Now?Cureus. 2021 Aug 9;13(8):e17022. doi: 10.7759/cureus.17022. eCollection 2021 Aug. Cureus. 2021. PMID: 34522503 Free PMC article. Review.
-
Rationale and Design of a Clinical Trial to Evaluate the Safety and Efficacy of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With Acute Myocardial Infarction and Left Ventricular Dysfunction: The Randomized Multicenter Double-Blind Controlled CAREMI Trial (Cardiac Stem Cells in Patients With Acute Myocardial Infarction).Circ Res. 2017 Jun 23;121(1):71-80. doi: 10.1161/CIRCRESAHA.117.310651. Epub 2017 May 22. Circ Res. 2017. PMID: 28533209 Clinical Trial.
Cited by
-
Functional expression of smooth muscle-specific ion channels in TGF-β(1)-treated human adipose-derived mesenchymal stem cells.Am J Physiol Cell Physiol. 2013 Aug 15;305(4):C377-91. doi: 10.1152/ajpcell.00404.2012. Epub 2013 Jun 12. Am J Physiol Cell Physiol. 2013. PMID: 23761629 Free PMC article.
-
Intravenous xenogeneic transplantation of human adipose-derived stem cells improves left ventricular function and microvascular integrity in swine myocardial infarction model.Catheter Cardiovasc Interv. 2015 Aug;86(2):E38-48. doi: 10.1002/ccd.25566. Epub 2015 Apr 24. Catheter Cardiovasc Interv. 2015. PMID: 24905889 Free PMC article.
-
Intracoronary and retrograde coronary venous myocardial delivery of adipose-derived stem cells in swine infarction lead to transient myocardial trapping with predominant pulmonary redistribution.Catheter Cardiovasc Interv. 2014 Jan 1;83(1):E17-25. doi: 10.1002/ccd.24659. Epub 2013 Oct 7. Catheter Cardiovasc Interv. 2014. PMID: 22972685 Free PMC article.
References
-
- Beltrami AP, Urbanek K, Kajstura J, et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med. 2001;344:1750–1757. - PubMed
-
- Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410:701–705. - PubMed
-
- Wojakowski W, Tendera M, Michałowska A, et al. Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation. 2004;110:3213–3220. - PubMed
-
- Kucia M, Reca R, Jala VR, Dawn B, Ratajczak J, Ratajczak MZ. Bone marrow as a home of heterogenous populations of nonhematopoietic stem cells. Leukemia. 2005;19:1118–1127. - PubMed
LinkOut - more resources
Full Text Sources